US structural heart occlusion market surges amid tariff concern
The US structural heart occlusion (SHO) market recorded a strong 39% year-over-year revenue increase in the first quarter (Q1) of…
The US structural heart occlusion (SHO) market recorded a strong 39% year-over-year revenue increase in the first quarter (Q1) of…
With the surge in tariffs imposed by and on the US, the medical devices industry is likely to be impacted…
The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery disease (CAD)…
The integration of patient data into digital health platforms is a transformative step in modern healthcare, particularly in the field…
US-based multinational Johnson & Johnson (J&J) has announced that it will be investing $55bn in new US manufacturing facilities over…
Echocardiography, a widely used noninvasive procedure that employs ultrasound to examine the heart, plays a pivotal role in diagnosing cardiovascular…
Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the…
Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of cardiac valve repair devices…
The Financial Times recently reported that Johnson & Johnson (J&J) is considering the sale of Cerenovus, its neurovascular division. This…
Vitalacy's AI-powered Virtual Care system is revolutionising patient monitoring by minimising fall risks and easing caregiver workload pressures, according to…